Calendar Novartis AG Nyse

Equities

NVS

US66987V1098

Market Closed - Nyse 01:30:02 06/07/2024 am IST 5-day change 1st Jan Change
108.1 USD +1.26% Intraday chart for Novartis AG +1.57% +7.09%

Chart calendar Novartis AG

2a88.A7RqwB5ZVoTESkqC2DBs8opZNwitNkLzNAVFoKSKISo.S9M5mioSIcCqMHPVtXsJg7JgZECbRCyLYnMf-sm8cmIwhwz4dS0EtLEnfg~bdb93ca8222f8d157c0dbc4ea65c480f

Upcoming events on Novartis AG

18/07/2024 10:30 am Q2 2024 Earnings Release
18/07/2024 05:30 pm Q2 2024 Earnings Call
05/09/2024 Morgan Stanley Global Healthcare Conference
18/09/2024 Bank of America Merrill Lynch Global Healthcare Conference
25/09/2024 BNP Paribas Exane ESG Conference
26/09/2024 Baader Investment Conference
29/10/2024 11:30 am Q3 2024 Earnings Release
08/11/2024 ZKB Swiss Equity Conference
13/11/2024 UBS European Conference
20/11/2024 Investor Meeting - Day 1
21/11/2024 Investor Meeting - Day 2
29/01/2025 Q4 2024 Earnings Release (Projected)
29/04/2025 Q1 2025 Earnings Release (Projected)
17/07/2025 Q2 2025 Earnings Release (Projected)
28/10/2025 Q3 2025 Earnings Release (Projected)

Past events on Novartis AG

20/06/2024 JP Morgan European Healthcare Conference
19/06/2024 Citi European Healthcare Conference
03/06/2024 04:30 am American Society of Clinical Oncology Meeting
23/05/2024 Deutsche Bank dbAccess European Champions Conference
23/04/2024 05:30 pm Q1 2024 Earnings Call
23/04/2024 10:30 am Q1 2024 Earnings Release
07/03/2024 Détachement de for final dividend
05/03/2024 Annual General Meeting
03/03/2024 Muscular Dystrophy Association Clinical and Scientific Conference
31/01/2024 06:30 pm Q4 2023 Earnings Call
31/01/2024 11:30 am Q4 2023 Earnings Release
08/01/2024 10:05 pm JPMorgan Healthcare Conference
08/12/2023 San Antonio Breast Cancer Symposium
28/11/2023 07:00 pm R&D Day
15/11/2023 Wolfe Research Healthcare Conference
15/11/2023 UBS European Conference
14/11/2023 Credit Suisse Healthcare Conference
13/11/2023 09:00 pm Impact and Health Equity Conference
08/11/2023 UBS BioPharma Conference
24/10/2023 05:30 pm Q3 2023 Earnings Call

Past dividends on Novartis AG

07/03/2024 Annual 3.3 CHF
04/10/2023 0 CHF
09/03/2023 Annual 3.2 CHF
08/03/2022 Annual 3.1 CHF
04/03/2021 Annual 3 CHF
03/03/2020 Annual 2.95 CHF
09/04/2019 0 CHF
04/03/2019 Annual 2.85 CHF
06/03/2018 Annual 2.8 CHF
02/03/2017 Annual 2.75 CHF

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
47 445
47 897
-0.94%
48 659
49 074
-0.85%
51 626
51 902
-0.53%
50 545
51 352
-1.57%
45 440
46 810
-2.93%

49 224

EBITDA
Million USD
Released
Forecast
Spread
15 809
15 640
1.08%
16 845
16 496
2.12%
18 246
18 336
-0.49%
18 613
17 036
9.25%
17 937
18 223
-1.57%

19 358

EBIT
Million USD
Released
Forecast
Spread
14 112
14 152
-0.28%
15 416
15 540
-0.8%
16 588
16 712
-0.74%
16 665
16 417
1.51%
16 372
16 735
-2.17%

18 265

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
8 940
9 963
-10.27%
9 878
10 184
-3%
26 137
18 886
38.39%
8 371
10 562
-20.74%
9 123
10 323
-11.63%

13 310

Net income
Million USD
Released
Forecast
Spread
7 147
8 481
-15.73%
8 072
8 392
-3.81%
24 021
23 336
2.93%
6 955
8 563
-18.78%
14 854
10 329
43.8%

10 684

EPS
USD
Released
Forecast
Spread
3,12
3,88
-19.63%
3,55
3,68
-3.52%
10,7
10,3
3.79%
3,19
4,06
-21.46%
7,15
5,38
32.95%

5,15

Announcement Date29/01/2026/01/2102/02/2201/02/2331/01/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD
Released
Forecast
Spread
12 531
12 640
-0.86%
12 781
12 767
0.11%
12 543
12 737
-1.52%
12 690
13 138
-3.41%
12 953
12 567
3.07%
13 622
13 270
2.65%
11 782
11 373
3.6%
11 423
11 773
-2.97%
11 829
11 498
2.88%

12 296


12 471


12 608


12 260


12 510

EBITDA
Million USD
Released
Forecast
Spread
4 407
4 039
9.12%
4 989


4 783
3 239
47.69%
4 473
4 104
8.99%



4 668





4 224
4 775
-11.55%


















EBIT
Million USD
Released
Forecast
Spread
4 083
4 092
-0.23%
4 270
4 159
2.67%
4 282
4 237
1.06%
4 030
3 741
7.71%
4 413
4 078
8.22%
4 668
4 446
5%
4 405
4 339
1.52%
3 821
4 094
-6.66%
4 537
4 220
7.52%

4 643


4 754


4 505


4 980


4 920

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
2 669
2 838
-5.95%
2 042
2 548
-19.86%
1 919
2 619
-26.73%
1 741
2 521
-30.94%
2 740
2 797
-2.04%
2 769
3 194
-13.31%
1 552
3 240
-52.1%
2 377
3 495
-31.99%
3 129
3 453
-9.38%

3 896


3 877


3 695







Net income
Million USD
Released
Forecast
Spread
2 222
2 313
-3.93%
1 695
2 340
-27.56%
1 575
2 379
-33.79%
1 466
2 919
-49.78%
2 293
2 268
1.1%
2 316
2 596
-10.8%
1 513
2 786
-45.69%
8 480
6 890
23.08%
2 688
2 459
9.31%

2 820


2 826


2 481







EPS
USD
Released
Forecast
Spread
1,00
1,04
-3.41%
0,77
1,05
-26.4%
0,73
1,17
-37.81%
0,69
1,35
-48.9%
1,09
1,07
1.82%
1,11
1,26
-11.75%
0,73
1,34
-45.68%
4,14
2,87
44.31%
1,31
1,19
10.18%

1,38


1,40


1,24







Announcement Date26/04/2219/07/2225/10/2201/02/2325/04/2318/07/2324/10/2331/01/2423/04/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise